Rheumatoid Arthritis-Critical Care

• Brand Name
• Olimab 60mg Injection

• Dosage Form
• Liquid

• Drug Type
• Injection

• Expiration Date
• 1836 Months

• Indication
• Osteoporosis

• Ingredients
• Olimab 60mg Injection contains Denosumab, a monoclonal antibody used to treat osteoporosis and other conditions associated with bone loss. It is commonly prescribed for postmenopausal women and men at high risk of fractures, helping to strengthen bones and reduce the likelihood of broken bones. Olimab 60mg Injection is also used to prevent bone-related complications in patients with certain cancers, including multiple myeloma and cancers that have spread to the bones. It works by blocking RANK ligand, a protein responsible for bone breakdown, thereby increasing bone density and improving bone strength. Adequate calcium and vitamin D supplementation is essential during treatment to support bone health and reduce the risk of low calcium levels. Patients with moderate kidney impairment may require close monitoring of renal function while receiving this medication. Olimab 60mg Injection should not be used by individuals with a known allergy to Denosumab or any of its ingredients and should be used cautiously in patients with pre-existing hypoparathyroidism. As its safety and effectiveness have not been established in children and adolescents, this medication is not recommended for individuals under 18 years of age. When used as prescribed, Olimab 60mg Injection can play an important role in managing osteoporosis and protecting against bone-related complications.

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1

• Physical Form
• Liquid

• Quantity
• 5 Unit

• Recommended For
• Osteoporosis

• Salt Composition
• Denosumab

• Storage
• Cool & Dry Place

• Usage
• Personal

• Brand Name
• Bonista PF Injection

• Dosage
• Injection

• Dosage Form
• Injection

• Drug Type
• Injection

• Function
• Arthritis Aid

• Indication
• osteoporosis

• Ingredients
• Teriparatide Injection is a bone-forming medication used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures or who have not responded adequately to other osteoporosis treatments. It works by stimulating new bone growth, increasing bone mineral density, and strengthening bones to reduce the risk of fractures. Available in injection, cartridge, and pen formulations, Teriparatide is administered as a once-daily subcutaneous injection into the thigh or abdominal area, with or without food, as directed by a healthcare professional. Common side effects may include joint pain, headache, nausea, dizziness, neck pain, constipation, diarrhea, indigestion, vomiting, hypertension, rash, sweating, cough, insomnia, depression, and vertigo. Patients should seek medical attention if they experience injection-site reactions such as swelling, bruising, itching, or severe allergic symptoms. Teriparatide is not recommended for individuals with an increased risk of bone cancer, including those with Paget s disease, hereditary bone disorders, skeletal malignancies, hypercalcemia, urolithiasis (kidney stones), or orthostatic hypotension. Before starting treatment, patients should inform their doctor about any history of heart disease, bone disorders, kidney problems, or other significant medical conditions. Regular monitoring of blood calcium levels, urine calcium levels, and kidney function may be required during therapy to help ensure safe and effective treatment outcomes.

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1

• Physical Form
• Liquid

• Quantity
• 1 Pieces

• Recommended For
• osteoporosis

• Salt Composition
• Teriparatide

• Storage
• Store in a refrigerator (2 - 8C). Do not freeze.

• Storage Instructions
• Store at controlled room temperature, between 20 C to 25 C (68 F to 77 F).

• Suitable For
• Suitable For All

• Usage
• Osteoporosis

• Dosage
• As Per Instructions

• Dosage Form
• Injection

• Drug Type
• Injection

• Ingredients
• Olimab 60mg Injection contains Denosumab, a monoclonal antibody used to treat osteoporosis and other conditions associated with bone loss. It is commonly prescribed for postmenopausal women and men at high risk of fractures, helping to strengthen bones and reduce the likelihood of broken bones. Olimab 60mg Injection is also used to prevent bone-related complications in patients with certain cancers, including multiple myeloma and cancers that have spread to the bones. It works by blocking RANK ligand, a protein responsible for bone breakdown, thereby increasing bone density and improving bone strength. Adequate calcium and vitamin D supplementation is essential during treatment to support bone health and reduce the risk of low calcium levels. Patients with moderate kidney impairment may require close monitoring of renal function while receiving this medication. Olimab 60mg Injection should not be used by individuals with a known allergy to Denosumab or any of its ingredients and should be used cautiously in patients with pre-existing hypoparathyroidism. As its safety and effectiveness have not been established in children and adolescents, this medication is not recommended for individuals under 18 years of age. When used as prescribed, Olimab 60mg Injection can play an important role in managing osteoporosis and protecting against bone-related complications.

• Physical Form
• Liquid

• Storage Instructions
• Dry And Cool Place

• Dosage
• 5 mg

• Dosage Form
• Tablets

• Drug Type
• General Medicines

• Ingredients
• Tofacitinib 5mg

• Physical Form
• Tablets

• Storage Instructions
• Dry And Cool Place

• Dosage
• 40 mg / 0.8 ml

• Drug Type
• Injection

• Ingredients
• Adalimumab

• Recommended For
• Plamumab 40mg Injection is a medicine used to treat a variety of conditions such as ankylosing spond

• Storage Instructions
• Dry And Cool Place

• Brand Name
• Denosurel 120mg Injection

• Dosage
• 120mg

• Dosage Form
• Injection

• Drug Type
• Injection

• Indication
• osteoporosis

• Ingredients
• Denosurel 120mg Injection contains Denosumab, a targeted medication used to strengthen bones and prevent bone-related complications in patients with osteoporosis, multiple myeloma, and cancers that have spread to the bones (bone metastases). It works by blocking RANK ligand, a protein involved in bone breakdown, helping to reduce bone loss, increase bone density, and lower the risk of fractures. Clinical studies have shown that Denosumab can significantly improve bone strength in postmenopausal women with osteoporosis and individuals experiencing cancer-related bone loss. Patients receiving Denosurel 120mg Injection should ensure adequate calcium and vitamin D intake throughout treatment to support healthy bone metabolism and reduce the risk of low calcium levels. Individuals with moderate kidney impairment may require regular monitoring of renal function during therapy. This medication should not be used by patients with a known allergy to Denosumab or any of its ingredients and should be administered with caution in those with pre-existing hypoparathyroidism. As the safety and effectiveness of Denosurel 120mg Injection have not been established in children and adolescents, it is not recommended for individuals under 18 years of age. When used under medical supervision, Denosurel 120mg Injection can play an important role in protecting bone health and preventing serious skeletal complications.

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1 VIAL

• Packaging Type
• vial

• Physical Form
• Liquid

• Quantity
• 1 Boxes

• Recommended For
• Denosurel 120mg Injection is a medicine used in the treatment of osteoporosis in postmenopausal wome

• Salt Composition
• Denosumab

• Storage Instructions
• Dry And Cool Place

• Suitable For
• Suitable For All

• Brand Name
• Exemptia 40mg Injection

• Dosage
• 40 mg / 0.8 ml

• Dosage Form
• injection

• Drug Type
• General Medicines

• Ingredients
• Exemptia 40mg Injection contains Adalimumab, a biologic disease-modifying antirheumatic drug (DMARD) that belongs to the tumor necrosis factor (TNF) inhibitor class. It is used to treat a variety of autoimmune and inflammatory conditions by reducing inflammation and controlling the overactive immune response that causes tissue damage. Exemptia 40mg Injection is prescribed for conditions such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn s disease, ulcerative colitis, and non-infectious uveitis. By blocking TNF, a key inflammatory protein in the body, this medication helps relieve symptoms such as joint pain, swelling, stiffness, skin lesions, and intestinal inflammation while improving overall quality of life. Exemptia 40mg Injection should not be used in patients who are allergic to Adalimumab, have active tuberculosis, severe infections, or moderate to severe heart failure. Before starting treatment, patients should inform their healthcare provider about any current infections, lung conditions, heart disease, liver or kidney disorders, and all medications they are taking. Women who are pregnant, planning a pregnancy, or breastfeeding should consult their doctor before using this medication. Regular medical monitoring may be recommended during treatment to ensure safety and maximize therapeutic benefits.

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1

• Physical Form
• Liquid

• Quantity
• 4 Pieces

• Recommended For
• Adults

• Salt Composition
• Adalimumab

• Storage Instructions
• Dry And Cool Place

• Suitable For
• Suitable For All

• Brand Name
• Remicade 100mg Injection

• Dosage Form
• Injection

• Drug Type
• General Medicines

• Indication
• Rheumatoid arthritis

• Ingredients
• Infliximab 100mg

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1 VIAL(s) OF 10ML

• Packaging Type
• 1 VIAL(s) OF 10ML

• Physical Form
• Liquid

• Quantity
• 1 Pieces

• Recommended For
• Rheumatoid arthritis

• Salt Composition
• Infliximab 100mg

• Storage Instructions
• Dry And Cool Place

• Suitable For
• Suitable For All

• Brand Name
• Infimab 100mg Injection

• Dosage
• 100 mg

• Dosage Form
• Injection

• Drug Type
• Injection

• Function
• Strengthen Bones

• Indication
• rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.

• Ingredients
• Infliximab

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1

• Physical Form
• Liquid

• Quantity
• 1 Boxes

• Salt Composition
• Infliximab

• Storage Instructions
• Dry And Cool Place

• Suitable For
• Suitable For All

• Brand Name
• Rozel 60mg Injection

• Dosage Form
• Injection

• Drug Type
• Injection

• Indication
• Osteoporosis

• Ingredients
• Rozel 60mg Injection contains Denosumab, a monoclonal antibody used to treat osteoporosis and prevent bone-related complications in patients with certain cancers, including multiple myeloma and cancers that have spread to the bones (bone metastases). By targeting and blocking RANK ligand, a protein responsible for bone breakdown, Rozel 60mg Injection helps increase bone density, strengthen bones, and reduce the risk of fractures. It is commonly prescribed for postmenopausal women with osteoporosis as well as patients experiencing cancer-related bone loss. The dosage and administration schedule are determined by a healthcare specialist and the injection is typically given under medical supervision in a clinical setting. Regular monitoring may be required during treatment to ensure safety and effectiveness. As Denosumab-based therapies are available under different brand names, patients should consult their doctor to understand the most suitable treatment option based on their condition, treatment goals, and overall health status. When used as prescribed, Rozel 60mg Injection can play a significant role in maintaining bone health and preventing serious skeletal complications.

• Origin of Medicine
• India

• Physical Form
• Liquid

• Quantity
• 5 Pieces

• Recommended For
• Osteoporosis

• Salt Composition
• Denosumab

• Storage Instructions
• 2-8 degree Celsius

• Suitable For
• Women, Aged Person, Suitable For All

• Dosage Form
• Injection

• Drug Type
• Injection

• Function
• Arthritis Aid

• Indication
• Rheumatoid Arthritis

• Ingredients
• Mabura 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factor-alpha (TNF- ), a key driver of inflammation in autoimmune diseases. It is used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and tissue damage, thereby improving quality of life. Mabura is administered as a subcutaneous injection, usually every two weeks, under medical supervision. Common side effects include injection site reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and prompt reporting of symptoms like fever, persistent cough, or unusual bruising are essential during treatment.

• Origin of Medicine
• India

• Packaging Type
• 1 prefilled syringe(s) of 0.8ml

• Physical Form
• Liquid

• Quantity
• 1 Pieces

• Recommended For
• Rheumatoid Arthritis

• Salt Composition
• ADALIMUMAB

• Suitable For
• Adults

• Drug Type
• Injection

• Ingredients
• Adfrar 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factor-alpha (TNF- ), a key mediator of inflammation in autoimmune diseases. It is used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and preventing further joint or tissue damage. Adfrar is administered as a subcutaneous injection, usually once every two weeks, under medical supervision. Common side effects include injection-site reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and immediate medical attention for symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin are essential during treatment.

• Origin of Medicine
• India

• Packaging Type
• pfs

• Physical Form
• Liquid

• Quantity
• 1 Pieces

• Recommended For
• Rheumatoid Arthritis

• Salt Composition
• ADALIMUMAB

• Suitable For
• Adults

• Dosage Form
• Injection

• Drug Type
• Injection

• Indication
• Rheumatoid Arthritis

• Ingredients
• Adalipca 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factor-alpha (TNF- ), a key inflammatory protein involved in autoimmune diseases. It is used to treat rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and preventing further joint or tissue damage. Adalipca is given as a subcutaneous injection, usually once every two weeks, under medical supervision. Common side effects include injection-site reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and prompt medical attention for symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin are essential during treatment.

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1 Prefilled Syringe(s) Of 0.8ml

• Packaging Type
• pfs

• Physical Form
• Liquid

• Quantity
• 1 Pieces

• Recommended For
• Adults

• Salt Composition
• Adalimumab

• Suitable For
• Adults

• Brand Name
• Denolite Injection

• Dosage Form
• Injection

• Drug Type
• Injection

• Indication
• osteoporosis

• Ingredients
• Denolite Injection is a prescription medication used to treat osteoporosis in postmenopausal women and men who are at an increased risk of fractures. It works by strengthening bones, improving bone density, and reducing the likelihood of bone fractures, helping patients maintain better skeletal health. This injection is administered by a healthcare professional and should not be self-injected. For the best treatment outcomes, it is important to follow the prescribed schedule and continue therapy for the duration recommended by your doctor. Adequate calcium and vitamin D supplementation is often advised during treatment to support bone strength and enhance the effectiveness of the medication. Common side effects of Denolite Injection may include headache, pain in the arms or legs, musculoskeletal pain, nerve pain, constipation, and skin rash. Patients should consult their healthcare provider if these side effects persist or become severe. Before starting treatment, inform your doctor about any existing medical conditions and all medications, supplements, or herbal products you are taking to help avoid potential interactions. Pregnant or breastfeeding women should seek medical advice before using Denolite Injection to ensure its safety and suitability.

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 1

• Physical Form
• Liquid

• Quantity
• 5 Unit

• Recommended For
• osteoporosis

• Salt Composition
• Denosumab

• Storage
• Store in a refrigerator (2 - 8C). Do not freeze.

• Storage Instructions
• Store in a refrigerator (2 - 8 C). Do not freeze.

• Suitable For
• Suitable For All

• Usage
• Osteoporosis